The Oncology Institute Statistics
Total Valuation
TOI has a market cap or net worth of $17.76 million. The enterprise value is $93.30 million.
Important Dates
The last earnings date was Wednesday, November 13, 2024, after market close.
| Earnings Date | Nov 13, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
TOI has 75.49 million shares outstanding. The number of shares has increased by 1.59% in one year.
| Current Share Class | 75.49M |
| Shares Outstanding | 75.49M |
| Shares Change (YoY) | +1.59% |
| Shares Change (QoQ) | +1.03% |
| Owned by Insiders (%) | 18.97% |
| Owned by Institutions (%) | 27.29% |
| Float | 45.91M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.05 |
| Forward PS | 0.08 |
| PB Ratio | 1.15 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.25 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.49, with a Debt / Equity ratio of 7.94.
| Current Ratio | 2.49 |
| Quick Ratio | 2.19 |
| Debt / Equity | 7.94 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -7.68 |
Financial Efficiency
Return on equity (ROE) is -160.85% and return on invested capital (ROIC) is -24.21%.
| Return on Equity (ROE) | -160.85% |
| Return on Assets (ROA) | -19.96% |
| Return on Capital (ROIC) | -24.21% |
| Revenue Per Employee | $473,666 |
| Profits Per Employee | -$68,805 |
| Employee Count | 800 |
| Asset Turnover | 1.91 |
| Inventory Turnover | 29.19 |
Taxes
| Income Tax | -314,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -90.78% in the last 52 weeks. The beta is 0.62, so TOI's price volatility has been lower than the market average.
| Beta (5Y) | 0.62 |
| 52-Week Price Change | -90.78% |
| 50-Day Moving Average | 0.31 |
| 200-Day Moving Average | 0.81 |
| Relative Strength Index (RSI) | 31.81 |
| Average Volume (20 Days) | 193,226 |
Short Selling Information
The latest short interest is 247,975, so 0.33% of the outstanding shares have been sold short.
| Short Interest | 247,975 |
| Short Previous Month | 251,810 |
| Short % of Shares Out | 0.33% |
| Short % of Float | 0.54% |
| Short Ratio (days to cover) | 3.38 |
Income Statement
In the last 12 months, TOI had revenue of $378.93 million and -$55.04 million in losses. Loss per share was -$0.77.
| Revenue | 378.93M |
| Gross Profit | 53.74M |
| Operating Income | -63.48M |
| Pretax Income | -57.85M |
| Net Income | -55.04M |
| EBITDA | -57.32M |
| EBIT | -63.48M |
| Loss Per Share | -$0.77 |
Full Income StatementBalance Sheet
The company has $47.40 million in cash and $122.95 million in debt, giving a net cash position of -$75.55 million or -$1.00 per share.
| Cash & Cash Equivalents | 47.40M |
| Total Debt | 122.95M |
| Net Cash | -75.55M |
| Net Cash Per Share | -$1.00 |
| Equity (Book Value) | 15.48M |
| Book Value Per Share | 0.20 |
| Working Capital | 69.67M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$34.62 million and capital expenditures -$2.90 million, giving a free cash flow of -$37.51 million.
| Operating Cash Flow | -34.62M |
| Capital Expenditures | -2.90M |
| Free Cash Flow | -37.51M |
| FCF Per Share | -$0.50 |
Full Cash Flow StatementMargins
Gross margin is 14.18%, with operating and profit margins of -16.75% and -18.53%.
| Gross Margin | 14.18% |
| Operating Margin | -16.75% |
| Pretax Margin | -18.62% |
| Profit Margin | -18.53% |
| EBITDA Margin | -15.13% |
| EBIT Margin | -16.75% |
| FCF Margin | -11.70% |